We have noted "around the traps" that some people are a little confused about the ownership of shares in Cellestis. In the interests of every shareholder knowing the correct facts we provide the shareholder details here.
Total Shares.
There are a touch over 96 million shares on issue (let's call it an even 96 million).
Shares Held or Controlled by the Directors of Cellestis.
Ron Pitcher 160,000 0.16%
Tony Radford 11,449,690 11.93%
Jim Rothel 11,449,689 11.93%
Prof. Antonio Catanzaro 175,000 0.18%
John Bennets 2,298,607 2.39%
Total 25,532,986 26.60%
____________________________________
Shares Held or controlled by Qiagen.
Qiagen hold exactly zero (that's nil) shares.
Note carefully that if they were to own any shares they are explicitly excluded from voting those shares.
What they do have is a highly conditional option to purchase 19.9% of the shares in the Company that belong to Tony Radford and Jim Rothel.
As part of that options agreement, TR and JR have agreed to vote that 19.9% in favor of the Scheme. Had Qiagen purchased the shares outright then they would have been prevented from voting those shares. It seems that this option arrangement avoids that exclusion.
It seems that this option agreement has been limited to be over only the 19.9% holding to avoid triggering the provisions of the takeover act. We would presume that the same consideration prevents Qiagen from buying any shares on or off market.
We will be covering the options agreement, the voting requirements and the Qiagen position post the Scheme in following emails. However, at this point it is important to understand that if this deal is voted down then Qiagen will hold NO shares in Cellestis.
Disclaimer. Nothing in this email should be construed as personal financial or legal advice. All information is provided on the understanding that you will take whatever steps are necessary to ensure that any actions that you take are the most approriate for your own personal circumstances. The author accepts no responsibility for the impact of any consequent outcomes.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.